Chandigarh-based Parabolic Drugs plans to launch 5 new molecules by end-April and is working on 20 new molecules in women health, diabetes and hypertension segments, a senior official said on Tuesday.
The firm expects its new unit in Punjab to add Rs1-1.5 billion to FY12 sales, Co-founder and Director Vineet Gupta told Reuters in an interview. The active pharmaceutical ingredients (API) maker had raised Rs 2 billion via a 26.6-million-share initial public offer in June last year.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
